Organisation paid for research Program year 2025 Source: CMS Open Payments

Dignity Health

Neither a doctor nor a teaching hospital

Research payments

$441,745

71 payments

Through program year 2025, Dignity Health is reported as receiving $441,745 in research payments, across 71 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$850	2
2024	Research	$2,660	1
2023	Research	$3,350	2
2022	Research	$53,968	7
2021	Research	$36	1
2020	Research	$89,115	20
2019	Research	$291,766	38

Breakdown

Who paid Research payments · program years 2019–2025

Novartis Pharmaceuticals Corporation $102,132 7 payments
Cardiovascular Systems Inc. $96,954 25 payments
Biogen, Inc. $88,231 5 payments
Exelixis Inc. $35,312 6 payments
Ucb SA $31,066 2 payments
Amgen Inc. $27,339 4 payments
ACADIA Pharmaceuticals Inc $17,300 1 payment
United Therapeutics Corporation $13,070 9 payments
Penumbra, Inc. $8,945 1 payment
Nevro Corp. $5,026 2 payments

Studies the money was for Research payments · program years 2019–2025

Exploring the Safety and Tolerability of Conversion to Dose Titrated Siponimod in Patients With Relapsing Forms of Multiple Sclerosis A 6 Month Open Label Multi Center Phase III B Study Expanded $102,013 4 payments
Eclipse $95,629 23 payments
A Randomized, Controlled Phase 3 Study of Cabozantinib XL184) in Combination with Atezolizumab versus Sorafenib in Subjects with Advanced Hepatocellular Carcinoma Who Have Not Received Previous Systemic Anticancer Therapy $35,312 6 payments
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB100 Administered Orally to Adults With Amyotrophic Lateral Sclerosis $34,760 1 payment
Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease $34,619 1 payment
The Healey Platform trial $22,332 1 payment
PMO Self Administration Study ++ $20,857 1 payment
Acp-103-063 $17,300 1 payment
Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease $12,860 1 payment
Extract-Pe $8,945 1 payment

What the money was spent on Research payments · program years 2019–2025

Patient care $96,954 25 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.